MONAMI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.806
EU - Europa 6.466
AS - Asia 4.913
SA - Sud America 930
Continente sconosciuto - Info sul continente non disponibili 170
AF - Africa 141
OC - Oceania 67
Totale 25.493
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.546
RU - Federazione Russa 2.463
IT - Italia 1.514
SG - Singapore 1.333
CN - Cina 1.061
HK - Hong Kong 893
BR - Brasile 743
PL - Polonia 698
VN - Vietnam 583
IE - Irlanda 537
SE - Svezia 382
KR - Corea 363
FR - Francia 229
DE - Germania 192
FI - Finlandia 181
IN - India 165
CA - Canada 144
BD - Bangladesh 114
GB - Regno Unito 91
JO - Giordania 81
AR - Argentina 65
AU - Australia 65
ID - Indonesia 58
EC - Ecuador 49
MX - Messico 48
UA - Ucraina 45
IQ - Iraq 44
TR - Turchia 44
JP - Giappone 43
CH - Svizzera 40
CI - Costa d'Avorio 33
ZA - Sudafrica 31
ES - Italia 24
CO - Colombia 19
NL - Olanda 18
MA - Marocco 16
PY - Paraguay 16
PH - Filippine 15
VE - Venezuela 15
PK - Pakistan 14
SA - Arabia Saudita 14
JM - Giamaica 13
CL - Cile 11
EG - Egitto 11
NG - Nigeria 11
AZ - Azerbaigian 10
HN - Honduras 10
UZ - Uzbekistan 10
DZ - Algeria 9
KZ - Kazakistan 9
LT - Lituania 9
BE - Belgio 7
CR - Costa Rica 7
IR - Iran 7
PT - Portogallo 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
KE - Kenya 6
NP - Nepal 6
UY - Uruguay 6
AL - Albania 5
BB - Barbados 5
BJ - Benin 5
MY - Malesia 5
PE - Perù 5
BH - Bahrain 4
IL - Israele 4
NI - Nicaragua 4
SV - El Salvador 4
TH - Thailandia 4
DK - Danimarca 3
LV - Lettonia 3
PS - Palestinian Territory 3
SC - Seychelles 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GP - Guadalupe 2
LB - Libano 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 25.302
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.465
Ashburn 1.562
Fairfield 1.096
Singapore 972
Hong Kong 773
Warsaw 694
Dublin 535
Chandler 526
Woodbridge 496
Seattle 487
San Jose 460
Cambridge 413
Houston 386
Seoul 356
Milan 355
Wilmington 345
Beijing 299
Lawrence 225
Altamura 224
Ho Chi Minh City 205
Council Bluffs 199
Ann Arbor 192
Moscow 184
Los Angeles 182
Princeton 172
Buffalo 149
Hanoi 141
The Dalles 140
Lauterbourg 134
Rome 123
Mumbai 113
Hefei 110
New York 104
Boston 101
Munich 84
San Diego 82
Boardman 79
Dallas 79
Florence 78
Medford 72
Helsinki 68
Phoenix 63
Shanghai 62
São Paulo 61
Melbourne 56
Chicago 48
Clifton 47
Paris 47
Kent 45
Toronto 43
Naples 39
Turin 38
Jacksonville 37
Bern 34
Tokyo 34
Abidjan 33
Turku 32
Bologna 30
Falls Church 29
Redondo Beach 28
Rio de Janeiro 28
Brooklyn 27
Figino 27
Izmir 27
Jakarta 27
Orem 24
Guangzhou 23
Hillsboro 23
London 23
Andover 22
Brasília 21
Frankfurt am Main 21
Atlanta 20
Quito 19
Baghdad 18
Da Nang 18
Montreal 18
Tianjin 18
Miano 17
Norwalk 17
Curitiba 16
Guayaquil 16
Mexico City 16
Bari 15
Biên Hòa 15
Denver 15
Palermo 15
Falkenstein 14
Lappeenranta 14
Belo Horizonte 13
Catania 13
Johannesburg 13
Padua 13
Ribeirão Preto 13
Dong Ket 12
Haiphong 12
Philadelphia 12
Porto Alegre 12
San Francisco 12
Thái Nguyên 12
Totale 16.977
Salva come PNG Salva come JPEG
Nome #
Resistin level in coronary artery disease and heart failure: the central role of kidney function 344
Left ventricular cavity obliteration during dobutamine stress echocardiography in diabetic patients 336
Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities 336
Sulphonylureas and cancer: a case-control study. 290
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. 257
Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity 254
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. 252
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 225
A randomized, open-label, controlled trial to evaluate the antimicrobial and surgical effect of CO2 laser treatment in diabetic infected foot ulcers: DULCIS (diabetic ulcer, CO2 laser, and infections) study 225
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction 224
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 220
Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies 218
Adherence to and early adverse events of COVID-19 vaccine in a cohort of 600 Italian breastfeeding and pregnant physicians 212
DPP-4 inhibitors and lipids: Systematic review and meta-analysis 211
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 207
Amphetamine derivatives and obesity 206
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: Meta-analysis of placebo-controlled trials 205
Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. 200
Targeting educational therapy for type 2 diabetes: Identification of predictors of therapeutic success 197
Age and comorbidity in acute myocardial infarction: a report from the AMI-Florence Italian registry 197
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 195
Alpha-Tocopherol and contrast-induced nephropathy: a meta-analysis of randomized controlled trials 193
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 191
Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials 190
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily 190
Fasting and post-prandial glucose and diabetic complication. A meta-analysis 189
Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials 187
Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy 187
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 186
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials 185
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? 184
CO2 laser for the treatment of diabetic foot ulcers with exposed bone. A consecutive series of type 2 diabetic patients 183
HbA1c levels and all-cause mortality in type 2 diabetic patients: Epidemiological evidence of the need for personalised therapeutic targets 182
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials 181
Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review 181
Priapus is Happier with Venus than with Bacchus 180
Low Testosterone is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction 180
Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials 180
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 179
Development of the Italian Clinical Practice Guidelines on Bariatric and Metabolic Surgery: Design and Methodological Aspects 178
Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials 175
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 175
Antimicrobial photodynamic therapy in infected diabetic foot ulcers: A multicenter preliminary experience 175
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 173
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials 173
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 173
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes 173
2023 update on Italian guidelines for the treatment of type 2 diabetes 172
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 172
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 171
Post-prandial glucose and diabetic complications: Systematic review of observational studies 171
Retrospective Matched Case-Control Study on the Use of CO2 Laser for the Treatment of Nonhealing Diabetic Foot Ulcers: The DULCIS-2 (Diabetic ULcer, CO2 Laser, and Infections) Study 170
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials 170
All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. 168
All-cause and cardiovascular mortality in a consecutive series of patients with diabetic foot osteomyelitis 168
Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials 167
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 166
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: A meta-analysis of randomized clinical trials 165
Dipeptidyl peptidase-4 inhibitors and bone fractures: A meta-analysis of randomized clinical trials 165
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 165
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 165
Deprescription in elderly patients with type 2 diabetes mellitus 164
Bone Fractures with Sodium-Glucose Co-transporter-2 Inhibitors: How Real is the Risk? 164
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 163
Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials 162
Efficacy and effects of bariatric surgery in the treatment of obesity: Network meta-analysis of randomized controlled trials 162
Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension 161
Bariatric Surgery for Patients with Overweight/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events 160
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 160
combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in type 1 diabetes: A randomized cross‐over trial 159
Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome 158
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 158
Severe Depressive Symptoms and Cardiovascular Risk in Subjects with Erectile Dysfunction 157
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 157
Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy 157
Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge 157
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials 157
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 157
Reply to Gaertner, K. and Frass, M 155
Potential Impact of Climate on Novel Corona Virus (COVID-19) Epidemic 155
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials 154
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 154
Safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of randomized clinical trials 153
Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review 152
Coronary artery disease screening in type II diabetic patients: Prognostic value of rest and stress echocardiography 152
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials 152
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 152
Hypertension and metabolic syndrome in the elderly 151
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. 151
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. 150
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 149
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 149
Self-management in patients with type 2 diabetes: Group-based versus individual education. A systematic review with meta-analysis of randomized trails 148
Major Amputation In Non-Healing Ulcers: Outcomes and Economic Issues. Data from a Cohort of Patients with Diabetic Foot Ulcers 148
Rosiglitazone and cardiovascular risk. 146
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials 146
Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials 146
[Psychological disorders and cardiovascular diseases] 145
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 145
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials 145
Totale 18.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022787 0 0 0 59 33 53 37 73 46 52 137 297
2022/20232.541 300 615 119 183 129 406 292 92 251 20 81 53
2023/2024880 42 92 152 47 54 76 44 172 22 85 62 32
2024/20256.929 219 733 449 1.042 2.042 885 101 484 347 173 224 230
2025/20267.941 759 990 572 711 966 288 850 447 473 435 256 1.194
2026/20271.605 398 247 706 254 0 0 0 0 0 0 0 0
Totale 25.493